Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies
Background While radiation and chemotherapy are primarily purposed for their cytotoxic effects, a growing body of preclinical and clinical evidence demonstrates an immunogenic potential for these standard therapies. Accordingly, we sought to characterize the immunogenic potential of radiation and ci...
Main Authors: | James W Hodge, Michelle R Padget, Kellsye P Fabian, Joshua T Kowalczyk, Diana C Lopez, Austin TK Hoke, Clint T Allen, Mario Hermsen, Nyall R London |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-12-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/10/12/e005752.full |
Similar Items
-
Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation
by: Kellsye P. Fabian, et al.
Published: (2022-11-01) -
Organoid and Spheroid Tumor Models: Techniques and Applications
by: Sreenivasulu Gunti, et al.
Published: (2021-02-01) -
Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach
by: Austin T.K. Hoke, et al.
Published: (2024-06-01) -
Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies
by: Diana C. Lopez, et al.
Published: (2022-10-01) -
Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation
by: Ginette S. Santiago-Sánchez, et al.
Published: (2022-09-01)